305 related articles for article (PubMed ID: 11897766)
1. Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.
Redon J; Rovira E; Miralles A; Julve R; Pascual JM
Hypertension; 2002 Mar; 39(3):794-8. PubMed ID: 11897766
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.
Marin P; Julve R; Chaves FJ; Giner V; Pascual JM; Armengod ME; Redon J
J Hum Hypertens; 2004 Jan; 18(1):25-31. PubMed ID: 14688807
[TBL] [Abstract][Full Text] [Related]
3. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension.
Pascual JM; Rodilla E; Gonzalez C; Pérez-Hoyos S; Redon J
Hypertension; 2005 Jun; 45(6):1125-30. PubMed ID: 15897369
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
Widecka K; Celibała R; Czekalski S
Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231
[TBL] [Abstract][Full Text] [Related]
5. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
7. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
Leoncini G; Martinoli C; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Derchi LE; Deferrari G; Pontremoli R
Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
9. The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population.
Monster TB; Janssen WM; de Jong PE; de Jong-van den Berg LT;
Br J Clin Pharmacol; 2002 Jan; 53(1):31-6. PubMed ID: 11849192
[TBL] [Abstract][Full Text] [Related]
10. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
[TBL] [Abstract][Full Text] [Related]
11. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
Baumgart P; Reismann J; Pohlmeyer H; Düsing R
Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
[TBL] [Abstract][Full Text] [Related]
12. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
[TBL] [Abstract][Full Text] [Related]
13. [Factors associated with changes in microalbuminuria during antihypertensive treatment].
Rovira E; Julve R; Pascual JM; Miralles A; Redon J
Med Clin (Barc); 2000 May; 114(19):721-5. PubMed ID: 10919124
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
15. Body weight changes and the A-6G polymorphism of the angiotensinogen gene.
Chaves FJ; Giner V; Corella D; Pascual J; Marin P; Armengod ME; Redon J
Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1173-8. PubMed ID: 12187393
[TBL] [Abstract][Full Text] [Related]
16. Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension.
Redon J; Chaves FJ; Liao Y; Pascual JM; Rovira E; Armengod ME; Cooper RS
Hypertension; 2000 Jan; 35(1 Pt 2):490-5. PubMed ID: 10642347
[TBL] [Abstract][Full Text] [Related]
17. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
18. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.
Rodilla E; Pascual JM; Costa JA; Martin J; Gonzalez C; Redon J
J Hypertens; 2013 Aug; 31(8):1683-91. PubMed ID: 23835910
[TBL] [Abstract][Full Text] [Related]
19. Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.
Crepaldi G; Carraro A; Brocco E; Adezati L; Andreani D; Bompiani G; Brunetti P; Fedele D; Giorgino R; Giustina G
Acta Diabetol; 1995 Oct; 32(3):203-8. PubMed ID: 8590792
[TBL] [Abstract][Full Text] [Related]
20. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
